| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |